Qube Research & Technologies (QRT)’s Zevra Therapeutics ZVRA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.8M	Buy	1,241,343 +399,024	+47%	+$4.44M	0.02%	970
2026 Q1	$7.85M	Buy	842,319 +486,076	+136%	+$4.38M	0.01%	1426
2025 Q4	$3.19M	Buy	356,243 +49,754	+16%	+$471K	﹤0.01%	2012
2025 Q3	$2.91M	Buy	306,489 +295,201	+2,615%	+$2.96M	﹤0.01%	2043
2025 Q2	$99.4K	Buy	+11,288	New	+$91.6K	﹤0.01%	3036
2023 Q1	–	Sell	-30,259	Closed	-$139K	–	3113
2022 Q4	$139K	Buy	30,259 +8,426	+39%	+$42.8K	﹤0.01%	1920
2022 Q3	$136K	Sell	21,833 -3,017	-12%	-$17.1K	﹤0.01%	1885
2022 Q2	$111K	Buy	+24,850	New	+$113K	﹤0.01%	1908

Other funds holding ZVRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ZVRA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Zevra Therapeutics (ZVRA) stake by 47% in Q2 2026, buying an estimated $4.44M and bringing the position to 1,241,343 shares worth $17.8M. The position accounts for 0.02% of the portfolio, ranked #970.

Qube Research & Technologies (QRT) first reported a position in ZVRA in Q2 2022 and has held it in 8 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

Qube Research & Technologies (QRT) held 1,241,343 shares of Zevra Therapeutics worth $17.8M as of Q2 2026.
Qube Research & Technologies (QRT) bought 399,024 Zevra Therapeutics shares in Q2 2026, an estimated $4.44M.
Zevra Therapeutics made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #970 holding.
Qube Research & Technologies (QRT) first reported a position in Zevra Therapeutics in Q2 2022 and has held it in 8 quarters since.
157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.